Canada - Toronto Stock Exchange - TSX:DR - CA58457V5036 - Common Stock
ChartMill assigns a Buy % Consensus number of 42% to DR.CA. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-11-12 | Leede Jones Gab | Downgrade | Hold |
| 2022-11-11 | RBC Royalbank | Downgrade | Sector Perform |
| 2022-11-11 | National Bank of Canada Financial | Downgrade | |
| 2022-09-15 | National Bank of Canada Financial | Initiate | Sector Perform |
| 2022-05-16 | RBC Royalbank | Downgrade | Sector Perform |
| 2022-05-13 | National Bank of Canada Financial | Downgrade | Sector Perform |
| 2022-03-11 | RBC Royalbank | Upgrade | Sector Perform |
| 2022-03-11 | National Bank of Canada Financial | Upgrade | Outperform |
| 2021-11-12 | NationalBankFinancial | Downgrade | Outperform |
| 2021-11-12 | RBCRoyalBank | Upgrade | Sector Perform |
| 2021-09-07 | National Bank Financial | Upgrade | Outperform |
| 2021-05-14 | National Bank Financial | Upgrade | Outperform |
| 2021-05-14 | RBC Capital | Upgrade | Sector Perform |
| 2021-03-15 | RBC Capital | Upgrade | Sector Perform |
9 analysts have analysed DR.CA and the average price target is 16.58 CAD. This implies a price increase of 14.79% is expected in the next year compared to the current price of 14.44.
The consensus rating for MEDICAL FACILITIES CORP (DR.CA) is 42.2222 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
The number of analysts covering MEDICAL FACILITIES CORP (DR.CA) is 9.